ExaCare is a technology company.
ExaCare has raised $31.0M across 2 funding rounds.
ExaCare has raised $31.0M in total across 2 funding rounds.
ExaCare is an AI-native CRM platform designed for post-acute and senior care providers, with its core product Exa automating admissions workflows, extracting insights from referrals, and optimizing clinical and financial decisions.[1][2][5] It serves skilled nursing facilities, senior living providers, and home care organizations—used in over 1,500 facilities like National Health Care Associates and Monarch Healthcare Management—by solving inefficiencies in referral triage, manual data entry, and reimbursement maximization through features like PDPM estimates, insurance checks, and PointClickCare integration.[1][3][4][5] The platform has processed 2.9 million referrals and 21 million documents, recently raising $30 million in Series A funding led by Insight Partners to expand its AI agents for broader post-acute operations.[4][5]
ExaCare was founded by Laird Russell (CEO) and Ben Willox, driven by Russell's personal experience with a three-and-a-half-year brain injury navigating medical care, which highlighted admissions bottlenecks.[1][2][4] Headquartered in New York, the idea emerged from a core question: "What if every post-acute care patient could be placed in the ideal setting for their needs?" sparking tools for streamlined admissions and real-time insights.[2] Early traction built on their healthcare and tech expertise, evolving into an AI operating system now backed by investors like Insight Partners, Foundation Capital, and post-acute operators, with a team advised by industry leaders like Ephram Ostreicher and Tim Fields.[2][4]
ExaCare stands out in post-acute care through AI agents that automate complex workflows, reducing manual work and enabling focus on patient outcomes:
ExaCare rides the AI agent wave in healthcare, targeting post-acute care's $100B+ U.S. market strained by staffing shortages, regulatory complexity (e.g., PDPM), and rising referrals amid aging populations.[1][4] Timing aligns with AI maturity for domain-specific models, post-COVID operational pressures, and investor focus on healthtech efficiency—its $30M Series A reflects this momentum.[4] By automating 80%+ of admissions grunt work, it influences the ecosystem: enabling facilities to boost census/profitability, standardize decisions, and free staff for care, while fostering AI adoption in fragmented skilled nursing (where 70% still rely on manual processes).[3][4][5]
ExaCare is poised to evolve from admissions specialist to full AI operating system for post-acute care, expanding agents for care coordination, home health, and predictive analytics with fresh Series A capital.[2][4] Trends like multimodal AI, real-time data interoperability, and value-based reimbursement will accelerate growth, potentially capturing 10-20% market share as facilities mandate auditable AI workflows. Its influence could reshape staffing models, tying back to that origin vision: ideal patient placement at scale, transforming fragmented care into efficient, outcome-driven networks.[2][4]
ExaCare has raised $31.0M in total across 2 funding rounds.
ExaCare's investors include Insight Partners, Michael Liou.
ExaCare has raised $31.0M across 2 funding rounds. Most recently, it raised $30.0M Series A in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2025 | $30.0M Series A | Insight Partners, Michael Liou | |
| Apr 1, 2022 | $1.0M Seed |